Table 3 Diagnostic utility of the different imaging modalities (per-patient analysis—histopathology available)
From: Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
Imaging modality | Sensitivity (%) 95% CI | Specificity (%) 95% CI | PPV (%) 95% CI | NPV (%) 95% CI | Accuracy (%) 95% CI |
|---|---|---|---|---|---|
18F-FDG PET/CT | 83.3 62.62–95.26 | 60.6 42.14–77.09 | 60.6 49.28–70.89 | 83.3 66.23–92.73 | 70.2 56.60–81.57 |
CT scan | 54.6 32.21–75.61 | 38.2 22.17–56.44 | 36.4 26.43–47.62 | 56.5 41.00–70.86 | 44.6 31.34–58.53 |
EBUS/TBNA | 83.3 35.88–99.58 | 90.9 58.72–99.77 | 83.3 42.72–97.10 | 90.9 62.33–98.37 | 88.2 63.56–98.54 |
Mediastinoscopy | 50 15.70–84.30 | 100 87.23–100.00 | 100 NA | 87.1 77.15–93.10 | 88.6 73.26–96.80 |